Mesalamine and Aricept drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mesalamine (mesalamine) and Aricept (donepezil hydrochloride). Common drug interactions include dementia alzheimer's type among females and headache among males.
The phase IV clinical study analyzes what interactions people have when they take Mesalamine and Aricept. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Mesalamine?
Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.
What is Aricept?
Aricept has active ingredients of donepezil hydrochloride. It is often used in alzheimer's disease. eHealthMe is studying from 24,756 Aricept users. Check the latest studies of Aricept.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14 people who take Mesalamine and Aricept together, and have interactions are studied.

What are the common drug interactions of Mesalamine and Aricept, by gender? *:
female:
- Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
- Confusional state
- Fall
- Arrhythmia (irregular heartbeat)
- Blood calcium increased
- Blood potassium increased
- Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
- Cardiomegaly (increased size of heart than normal)
- Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
- Decreased appetite
male:
- Headache (pain in head)
- Abnormal behaviour
- Glioblastoma (most common and most aggressive malignant primary brain tumour in humans)
- Hallucination, visual (seeing things that aren't there)
- Hyperventilation
- Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Metabolic alkalosis (too much bicarbonate in the blood)
- Muscle spasms (muscle contraction)
- Neck pain
What are the common drug interactions of Mesalamine and Aricept, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
- Confusional state
- Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
- Decreased appetite
- Delirium (wild excitement)
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Dyspnoea (difficult or laboured respiration)
- Dystonia (abnormal muscle tone)
- Electrolyte imbalance
- Eye pain
What are the existing conditions these people have? *
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 21.43%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 21.43%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 14.29%
- Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 14.29%
- Type 2 Diabetes: 1 person, 7.14%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 7.14%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 7.14%
- Dementia (madness): 1 person, 7.14%
- Depression: 1 person, 7.14%
- High Blood Pressure: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Mesalamine and Aricept?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Mesalamine (28,053 reports)
- Aricept (24,756 reports)
Browse all drug interactions of Mesalamine and Aricept:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mesalamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aricept:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mesalamine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aricept and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on mesalamine and donepezil hydrochloride (the active ingredients of Mesalamine and Aricept, respectively), and Mesalamine and Aricept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Amlodipine cause Alanine Aminotransferase Abnormal? - 24 seconds ago
- Could Ketalar cause Delirium? - 24 seconds ago
- Drug interactions of Augmentin and Dolutegravir - 27 seconds ago
- Could Altace cause Cardioactive Drug Level Decreased? - 34 seconds ago
- Loryna vs. Nuvaring, side effect and effectiveness comparison - 36 seconds ago
- Dermatomyositis and Cellulitis - 39 seconds ago
- Could Niacin cause Ligament Disorder? - 41 seconds ago
- Drug interactions of Pramine and Armour Thyroid - 43 seconds ago
- Drug interactions of Albuterol and Trusopt - a minute ago
- Behcet'S Syndrome and Muscle Spasms - a minute ago